Pharmagreen Biotech Inc. (PHBI)
OTCMKTS · Delayed Price · Currency is USD
0.0021
-0.0002 (-9.52%)
Feb 11, 2026, 3:56 PM EST

Pharmagreen Biotech Balance Sheet

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Cash & Equivalents
0000.010.030.01
Cash & Short-Term Investments
0000.010.030.01
Cash Growth
21.94%-77.99%-84.36%-68.32%107.44%-80.54%
Accounts Receivable
000---
Other Receivables
---000
Receivables
0.0900000
Inventory
0.010.010.01---
Prepaid Expenses
---0.20.350.25
Other Current Assets
--0.02---
Total Current Assets
0.10.010.030.210.370.27
Total Assets
0.10.10.120.210.370.27
Accounts Payable
0.790.80.740.110.130.11
Accrued Expenses
1.081.070.881.181.070.89
Short-Term Debt
0.130.130.130.10.040.04
Current Portion of Long-Term Debt
0.140.140.150.120.190.64
Other Current Liabilities
0.2710.310.410.591.49
Total Current Liabilities
2.413.142.211.912.033.17
Long-Term Debt
0.090.090.090.120.040.03
Total Liabilities
2.53.232.32.032.073.2
Common Stock
0.660.660.570.440.380.1
Additional Paid-In Capital
10.3210.3210.3610.269.683.97
Retained Earnings
-13.51-14.15-13.14-12.57-11.7-7.17
Comprehensive Income & Other
0.180.080.080.09-0.010.22
Total Common Equity
-2.35-3.09-2.13-1.78-1.65-2.89
Minority Interest
-0.05-0.05-0.05-0.05-0.05-0.05
Shareholders' Equity
-2.4-3.13-2.18-1.82-1.69-2.93
Total Liabilities & Equity
0.10.10.120.210.370.27
Total Debt
0.350.360.370.340.270.71
Net Cash (Debt)
-0.35-0.36-0.37-0.33-0.24-0.7
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.00-0.01
Filing Date Shares Outstanding
663.65663.65663.65454.76385.17245.61
Total Common Shares Outstanding
663.65663.65573.46442.26381.1795.81
Working Capital
-2.31-3.13-2.18-1.7-1.65-2.9
Book Value Per Share
-0.00-0.00-0.00-0.00-0.00-0.03
Tangible Book Value
-2.35-3.09-2.13-1.78-1.65-2.89
Tangible Book Value Per Share
-0.00-0.00-0.00-0.00-0.00-0.03
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.